Mestag Therapeutics

We have an exciting NEW opportunity for a Senior Financial Controller to join and lead our small dynamic and friendly finance team based in Chesterford! We are now transitioning our lead programme into clinic - There has never been a better time to join us! #TeamMestag Check out the full job description below and apply using the link provided! https://lnkd.in/eY_rT3uV

We are excited to announce that we have entered into a collaboration with MSD, which deploys Mestag’s proprietary RAFT platform to interrogate the pathogenic role of fibroblasts in inflammatory disease for novel target discovery. Read more: https://bit.ly/3Bzfjvf

We are excited to announce that we have entered into a collaboration with MSD, which deploys Mestag’s proprietary RAFT platform to interrogate the pathogenic role of fibroblasts in inflammatory disease for novel target discovery. Read more: https://bit.ly/3Bzfjvf

Team Mestag took to the “college backs” of Cambridge with a traditional punting tour, making time to appreciate our beautiful city and the fun company of our colleagues!

Our CEO Susan Hill will be joining a panel discussion on pharma business development at the Sidley Healthcare Investment Conference. Contact us if you’re attending and want to learn more about Mestag: https://lnkd.in/eSTACriA

We are thrilled to have been selected as a finalist for the 2024 Scrip Awards in the MSD Innovation Award category for our antibodies that modulate fibroblast-immune interactions and our RAFT target discovery platform. Tune in on December 4th when the winners will be announced. https://lnkd.in/ev9Kv-5E

Last weekend, Mestag employees participated in a dragon boat racing event to support the new Cambridge Cancer Research Hospital and its mission to “unite the NHS, academia and industry in a powerful collaboration that will pioneer new ways to detect cancer earlier and treat it in a more personalised way.” Find out more: https://lnkd.in/equGpdNN

Team Mestag will be at #ESMO24 in Barcelona. If you are attending and would like to learn more about Mestag’s groundbreaking MST-0300 program, designed to conditionally induce Tertiary Lymphoid Structures in tumors, please reach out here: https://lnkd.in/eSTACriA

PhD/Post-doc Intern - Corporate Development, 6 months (Temporary) Chesterford research Park – Cambridge / Remote / Hybrid Part-time, 6 month contract - (10-20 hours per week     Are you in the last year of your PhD in biomedical sciences, just graduated or are doing a Post-Doc and are considering a career in life sciences business or corporate development?    This is an outstanding opportunity to join our Corporate Development team as a part-time Intern to get exposure and gain experience in business and corporate development.    Check out the opening below.   https://lnkd.in/eZjqv9rR

Mestag is honored to have been awarded a “Transforming Cancer Therapeutics” grant of £1.5/$1.9 million from @InnovateUK to accelerate MST-0300, which is designed to induce TLS in solid tumors, as an exciting and novel therapeutic approach. Read more: http://bit.ly/4cGFOLT @UKRI_News